Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS

Clinical trial NCT07197944 · RECRUITING

Trial details

NCT number: NCT07197944
Sponsor: Zealand Pharma
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Short Bowel Syndrome

Start date: 2026-02-11
Primary completion: 2028-10-23
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.